Supplementary Figure 2 from Metastatic Prostate Cancers with BRCA2 versus ATM Mutations Exhibit Divergent Molecular Features and Clinical Outcomes

Tumor mutation burden (muts/Mb) of ATM and BRCA2 mutant mPCs.

Збережено в:

Бібліографічні деталі
Автор:	Justin Hwang (15925675) (author)
Інші автори:	Xiaolei Shi (15925678) (author), Andrew Elliott (15925681) (author), Taylor E. Arnoff (14963396) (author), Julie McGrath (15078600) (author), Joanne Xiu (15051480) (author), Phillip Walker (15925684) (author), Hannah E. Bergom (15925687) (author), Abderrahman Day (15925690) (author), Shihab Ahmed (15925693) (author), Sydney Tape (15925696) (author), Allison Makovec (15925699) (author), Atef Ali (15925702) (author), Rami M. Shaker (15925705) (author), Eamon Toye (15925708) (author), Rachel Passow (15925711) (author), John R. Lozada (15925714) (author), Jinhua Wang (15925717) (author), Emil Lou (14957109) (author), Kent W. Mouw (15925720) (author), Benedito A. Carneiro (15925723) (author), Elisabeth I. Heath (15024674) (author), Rana R. McKay (15062884) (author), W. Michael Korn (15021032) (author), Chadi Nabhan (15051498) (author), Charles J. Ryan (15037635) (author), Emmanuel S. Antonarakis (14971443) (author)
Опубліковано:	2025
Предмети:	Cancer Molecular and Cellular Biology Genome Biology Comparative transcriptomics Functional genomics
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!

Supplementary Figure 2 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes